ASCIMIB 40 MG contains Asciminib, an advanced targeted therapy used in the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). It works by selectively inhibiting the abnormal BCR::ABL1 protein responsible for the uncontrolled growth of leukemia cells. This targeted mechanism helps slow disease progression, reduce leukemic cell activity, and support long-term disease management. ASCIMIB is particularly beneficial for patients who have experienced resistance, intolerance, or inadequate response to previous tyrosine kinase inhibitor (TKI) therapies. By targeting the underlying molecular cause of CML, it contributes to improved treatment outcomes and ongoing disease control under specialist supervision.
Each film-coated tablet contains:
Active Ingredient:
- Asciminib 40 mg
Pharmacological Class:
- BCR::ABL1 Tyrosine Kinase Inhibitor (STAMP Inhibitor)
Dosage Form:
- Film-Coated Tablet
ASCIMIB is formulated to provide targeted inhibition of leukemia-related cellular signaling pathways associated with chronic myeloid leukemia.
Why Choose RootAid Pharma?
Certified Quality
All medicines are sourced directly from verified manufacturers under strict temperature controls.
Secure & Discreet
We ensure 100% privacy and secure, tamper-proof packaging for all medical shipments.
Expert Support
Speak with a licensed professional for any questions regarding your medication.
Pregnancy
Consult DoctorPlease consult your physician before consuming any medicine during pregnancy.
Breastfeeding
Consult DoctorDiscuss with your doctor to understand the risks and benefits.
Alcohol
CautionAvoid consuming alcohol as it may cause adverse interactions with medications.
Driving
CautionCheck if your medicine causes drowsiness before driving or operating machinery.
